PolyPid Ltd
PYPD
View Detailed Chart
3.790USD
0.0000.00%
Close 11/03, 16:00（ET）Quotes delayed by 15 min
59.33MMarket Cap
LossP/E TTM
Intraday
1m
30m
1h
D
W
M
D
Today
0.00%
5 Days
+4.99%
1 Month
+8.29%
6 Months
+35.84%
Year to Date
+24.67%
1 Year
+14.85%
View Detailed Chart
TradingKey Stock Score of PolyPid Ltd
Currency: USD Updated: 2025-10-27Key Insights
Its valuation is considered fairly valued,and institutional recognition is very high. Over the past 30 days, multiple analysts have rated the company as a Buy. The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
PolyPid Ltd's Score
Support & Resistance
No Data
Score Analysis
Current score
Previous score
Analyst Rating
Based on
4
analysts
Buy
Current Rating
12.500
Target Price
+226.37%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
PolyPid Ltd Highlights
StrengthsRisks
Polypid Ltd is a biopharmaceutical company at the clinical stage, based in Israel . The company focuses on the development, production and commercialization of new, locally administered therapies to improve surgical results. The main product is PLEX technology, which is located in the place of surgery and ensures controlled and continuous delivery of medicines.
Undervalued
The company’s latest PE is -0.96, at a low 3-year percentile range.
Institutional Buying
The latest institutional holdings are 6.45M shares, increasing 22.47% quarter-over-quarter.
Held by James Simons
Star Investor James Simons holds 0.00 shares of this stock.
News
More news coming soon, stay tuned...
Financial Indicators
EPS
No Data
Total revenue
No Data
PolyPid Ltd Info
Polypid Ltd is a biopharmaceutical company at the clinical stage, based in Israel . The company focuses on the development, production and commercialization of new, locally administered therapies to improve surgical results. The main product is PLEX technology, which is located in the place of surgery and ensures controlled and continuous delivery of medicines.
Ticker SymbolPYPD
CompanyPolyPid Ltd
CEOMs. Dikla Czaczkes Akselbrad
Websitehttps://www.polypid.com
Related Instruments
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%Popular Symbols
